artenimol has been researched along with Cancer of Colon in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Alvarez, M; Blazquez, AG; Efferth, T; Fernandez-Dolon, M; Gomez-San Miguel, AB; Jansen, H; Maestre, AD; Marin, JJ; Romero, MR; Sanchez-Vicente, L; Serrano, MA | 1 |
| Chen, L; Hou, L; Jiang, TL; Lager, M; Li, CH; Liu, Z; Luo, Y; Wan, C; Wang, CZ; Wang, DH; Yuan, CS; Zhang, CF; Zhang, QH | 1 |
| Chai, Z; Li, J; Liu, C; Peng, Y; Qiu, J; Wang, X; Xu, J; Zheng, Y; Zhu, C | 1 |
| Chen, BF; Huang, YZ; Kang, XJ; Peng, HG; Wang, HY; Wu, AH; Xu, Q; Zhang, WY | 1 |
| Chen, G; Cui, B; Han, P; Li, J; Liu, Y; Luan, Y; Sun, Z; Yu, Z | 1 |
| Gao, CZ; Gong, XS; Jiang, RJ; Liao, XL; Ma, X; Xie, HD; Yang, B; Zhao, YL | 1 |
| Chen, SM; Ding, J; Lu, JJ; Meng, LH | 1 |
7 other study(ies) available for artenimol and Cancer of Colon
| Article | Year |
|---|---|
Novel artemisinin derivatives with potential usefulness against liver/colon cancer and viral hepatitis.
Topics: Animals; Artemisinins; Cell Line, Tumor; Cell Proliferation; Cell Survival; Colonic Neoplasms; Hepatitis, Viral, Human; Humans; Liver Neoplasms; Molecular Structure; Virus Replication | 2013 |
Effects of dihydroartemisinin, a metabolite of artemisinin, on colon cancer chemoprevention and adaptive immune regulation.
Topics: Apoptosis; Artemisinins; Chemoprevention; Colonic Neoplasms; Humans | 2022 |
Dihydroartemisinin synergistically enhances the cytotoxic effects of oxaliplatin in colon cancer by targeting the PHB2-RCHY1 mediated signaling pathway.
Topics: Antineoplastic Agents; Carcinogenesis; Cell Line, Tumor; Colonic Neoplasms; Humans; Oxaliplatin; Signal Transduction; Ubiquitin-Protein Ligases | 2023 |
Codelivery of dihydroartemisinin and doxorubicin in mannosylated liposomes for drug-resistant colon cancer therapy.
Topics: Animals; Antineoplastic Agents; Apoptosis; Artemisinins; Cell Line, Tumor; Cell Proliferation; Cell Survival; Colonic Neoplasms; Dose-Response Relationship, Drug; Doxorubicin; Drug Carriers; Drug Delivery Systems; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Female; Humans; Liposomes; Mice; Mice, Inbred BALB C; Mice, Nude; Structure-Activity Relationship | 2017 |
Small interfering RNA targeting Rac1 sensitizes colon cancer to dihydroartemisinin-induced cell cycle arrest and inhibited cell migration by suppressing NFκB activity.
Topics: Animals; Antineoplastic Agents; Apoptosis; Artemisinins; Cell Cycle Checkpoints; Cell Movement; Cell Proliferation; Cell Survival; Colonic Neoplasms; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; HCT116 Cells; Humans; Mice; Mice, Nude; NF-kappa B; rac1 GTP-Binding Protein; RNA Interference; RNA, Small Interfering; Tumor Burden; Xenograft Model Antitumor Assays | 2013 |
Synthesis, characterization and in vitro evaluation of a series of novel polyrotaxane-based delivery system for artesunate.
Topics: Antineoplastic Agents; Artemisinins; Artesunate; Calorimetry, Differential Scanning; Cell Line, Tumor; Colonic Neoplasms; Cyclodextrins; Drug Delivery Systems; Drug Evaluation; Humans; Magnetic Resonance Imaging; Poloxamer; Rotaxanes; X-Ray Diffraction | 2015 |
Characterization of dihydroartemisinin-resistant colon carcinoma HCT116/R cell line.
Topics: Annexins; Antineoplastic Agents; Apoptosis; Artemisinins; Artesunate; Carcinoma; Cell Cycle Checkpoints; Cell Proliferation; Colonic Neoplasms; Drug Resistance, Neoplasm; Gene Expression; HCT116 Cells; Heat-Shock Proteins; Humans; Phosphopyruvate Hydratase; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2012 |